Precision Menopause & Midlife Women's Health Care
Multilingual precision medicine platform for perimenopause, menopause, and long-term midlife health.
Precision hormone therapy, cardiometabolic risk reduction, and bone, brain, and gut health — guided by advanced biomarkers and systems-based medicine. Virtual care in multiple languages.
Your care journey in five steps
Step 1
Deep-Dive Consultation
A 60-minute virtual visit with your Medea clinician to understand your symptoms, health history, family risk, goals, and gaps in prior care.
Step 2
Precision Lab Testing
Targeted, insurance-friendly testing helps identify what may be driving symptoms and long-term risk across cardiometabolic health, inflammation, thyroid function, micronutrients, gut health, and relevant cancer risk signals.
Step 3
Your Personalized Protocol
An evidence-based, systems-based care plan built around your results. This may include insurance-friendly bioidentical hormone therapy when appropriate, nonhormonal options when needed, targeted nutrition, supplements, lifestyle interventions, and treatment guided by your biomarkers.
Step 4
Ongoing Clinical Support
Regular virtual follow-ups to monitor your response, adjust your plan, answer questions, and ensure you feel heard and supported.
Step 5
Longitudinal Health Tracking
Ongoing biomarker monitoring shows how your cardiovascular, metabolic, hormonal, bone, and cognitive health change over time — helping turn early intervention into long-term prevention.
Who Medea Health Is For
Medea is for the midlife woman who wants more than dismissal, delay, or one‑size‑fits‑all care. You may be navigating perimenopause or menopause, living with symptoms that disrupt daily life, or trying to understand long‑term risks before they become diagnoses.
You want evidence-based treatment.
You care about long-term risk, not just symptom relief.
You want systems-based clinical thinking.
You want care in your own language.
-
Most menopause platforms focus on managing hot flashes and prescribing HRT. Medea does that, and goes further. Every protocol is designed to relieve current symptoms while actively reducing long-term risk for cardiovascular disease, osteoporosis, type 2 diabetes, cognitive decline, and cancer. This dual focus is what makes Medea fundamentally different from standard menopause telehealth
-
Medea offers personalized menopausal hormone therapy (HRT/MHT) based on the latest evidence — right timing, right route, right dose, within the appropriate window for cardiovascular and bone protection. When hormones are contraindicated, Medea provides evidence-based nonhormonal approaches — because every woman deserves effective care regardless of her medical history.
-
Rather than treating each symptom in isolation, Medea evaluates interconnected systems — hormonal, metabolic, cardiovascular, gut, inflammatory, and cognitive — to find root causes and intervene early, often before disease appears on a standard panel.
-
Advanced testing reveals what is actually happening at the cellular and metabolic level. Protocols are built on data, adjusted based on data, and tracked over time with data — not guesswork, not symptom checklists alone.
-
Available in English, Georgian, Portuguese, Russian, and Spanish. Medea understands that health experiences, communication styles, and medical histories vary across cultures — and that midlife women from immigrant communities deserve care that reflects their lived reality.
Why Medea Is Different
The standard of care isn’t enough
For decades, midlife women have been told to simply "push through" the transition. You are given symptom checklists, generic advice, and rushed 10-minute appointments.
We built Medea Health because you deserve better.
You deserve care that is predictive, deeply personalized, and rooted in the latest science of aging and longevity.
Meet the Founder
Medea Health was founded on a singular, ambitious premise: the midlife transition should not be a period of simply managing symptoms, but a masterclass in vitality and resilience. We reject the outdated narrative of just 'getting through' perimenopause and menopause. Instead, we bring evidence-based, precision functional medicine to this critical window—the exact time when risks for cardiovascular disease, osteoporosis, cognitive decline, and metabolic shifts begin to accelerate.
The platform is the vision of Dr. Ketevan Shavliashvili, MD, MBA. As a physician-scientist, twice Harvard-certified specialist in midlife and menopause medicine, and PhD Candidate in Clinical and Translational Medicine, Dr. Shavliashvili identified a profound gap in standard healthcare. Drawing from her international clinical experience and her journey as a twice-immigrant, she built Medea Health to merge advanced science with deep cross-cultural understanding. Today, she designs proactive, prevention-focused protocols that serve women from all backgrounds, delivering a sophisticated standard of care that honors your unique biology and your entire story
"I built Medea to provide what midlife women deserve: comprehensive care built on precision medicine, functional biology, and deep respect for your whole story."
Dr. Ketevan Shavliashvili, MD, MBA, PhDc — Founder of Medea Health, menopause medicine specialist.
Join Our Founding Patient Cohort
Medea is in early launch. We're onboarding our first clinical team and our founding group of patients.
Personalized attention as we refine our protocols with real patient feedback
Founding patient pricing (details shared after your application
You'll work directly with our clinical team using protocols developed by Dr. Shavliashvili
What this means for you:
Opportunity to shape the future of precision midlife care
Once enrolled, your care is managed on our secure, HIPAA-compliant clinical platform with fully encrypted communication.
Board-certified clinicians.